Filter posts

Is the Myriad Case Decision and/or the DOJ Brief TRIPS Compliant?

Judge Sweet seemed to dismiss Myriad’s constitutional taking and TRIPS claims by indicating: “Finally, Myriad’s suggestion that invalidating …

BIO Press Release: BIO and AUTM file Amicus Brief in Myriad Case

The Biotechnology Industry Organization (BIO) filed an amicus brief in the U.S. Court of Appeals …

This Friday: Genetic Alliance Hosts Webinar on Myriad Gene Patent Case

Genetic Alliance Hosts Webinar on Myriad Gene Patent Case on Friday, April 30, 2010.

A Disin‘gene’uous Lawsuit: ACLU Challenges DNA Patents

From the mass production of life-saving medicines in cell cultures to the screening of our …

Burrill Report Podcast: Implications of Gene Patent Ruling

The Burrill Report podcast on the impact of the recent decision invalidating patents on genetic …

Tomorrow: BIO is "To the Point" on Gene Patenting

BIO is participating in an NPR segment at approximately 2:08pm ET tomorrow on the nationally-syndicated …

Tomorrow Morning on NPR: BIO, ACLU Discuss Gene Patenting

You can listen from your desk at http://www.wbur.org/listen. Callers will have the opportunity to ask …

Department of State: Foster Climate Change Solutions, Biodiversity, & Economic Development with IPR ...

CropLife has recently published their newest video interview last week with Carrie LaCrosse, of the …

BIO to USA Today: Patents Promote Innovation

Public debate over access to, and use of, genetic technology is a good thing. It …

Patent Docs: Falsehoods, Distortions and Outright Lies in the Gene Patenting Debate

Patent Docs blog reviewed the most repeated criticisms of the patenting of genetic materials, providing …